Clopidogrel treatment ( DrugBank: Clopidogrel )


1 disease
告示番号疾患名(ページ内リンク)臨床試験数
51全身性強皮症1

51. 全身性強皮症


臨床試験数 : 525 薬物数 : 565 - (DrugBank : 148) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 217
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05098704
(ClinicalTrials.gov)
June 22, 20224/10/2021Preventive Effect of Clopidogrel on the Systemic Sclerosis Development RiskPhase II/III Double-blind Randomized Placebo-controlled Trial Assessing the Preventive Effect of Clopidogrel on the Systemic Sclerosis Development Risk in Subjects With Specific Dysimmunity and Raynaud PhenomenonScleroderma;Systemic SclerosisDrug: clopidogrel treatment;Drug: PlaceboUniversity Hospital, BordeauxMinistry for Health and Solidarity, FranceRecruiting18 Years85 YearsAll90Phase 2/Phase 3France